Abstract:Intracellular bacterial pathogens, such as Staphylococcus aureus, that may hide in intracellular vacuoles represent the most significant manifestation of bacterial persistence. They are critically associated with chronic infections and antibiotic resistance, as conventional antibiotics are ineffective against such intracellular persisters due to permeability issues and mechanistic reasons. Direct subcellular targeting of S. aureus vacuoles suggests an explicit opportunity for the eradication of...

What problem does this paper attempt to address?

The problem this paper attempts to address is: How to effectively eliminate intracellular *Staphylococcus aureus* persisters through precise subcellular targeting techniques. ### Background *Staphylococcus aureus* is an important pathogen that can invade host cells and survive within intracellular vacuoles. This intracellular survival strategy gives the bacteria significant advantages in chronic infections and antibiotic resistance. Traditional antibiotics are less effective against these intracellular persisters due to limitations in permeability and mechanisms. Therefore, directly targeting the intracellular vacuoles where *Staphylococcus aureus* resides is considered an effective method to eliminate these persisters. However, a comprehensive understanding of the chemical biology properties and the importance of precise targeting of intracellular vacuoles remains limited. ### Research Objectives This paper reports a peptide mimic based on oligonucleotides that can effectively target and eliminate intracellular *Staphylococcus aureus* persisters. The study aims to reveal the mechanistic link between precise targeting and intracellular antibacterial effects and to verify the importance of precise targeting. ### Main Findings 1. **High Cellular Uptake**: The oligonucleotide efficiently enters cells through receptor-mediated endocytosis and co-localizes with *Staphylococcus aureus* persisters in phagolysosomes. 2. **Dual Targeting Mechanism**: The oligonucleotide effectively kills intracellular persisters through a dual mechanism of disrupting bacterial membranes and binding to bacterial DNA. This mechanism is not affected by the bacterial dormant state. 3. **Importance of Precise Targeting**: By altering the intracellular localization of the bacteria, researchers directly demonstrated the critical role of precise targeting in enhancing antibacterial effects. 4. **Biocompatibility**: This design strategy reduces interactions with other subcellular organelles, improving the biocompatibility of the peptide mimic, which shows good bacterial targeting and therapeutic effects in animal models. ### Conclusion Precisely targeting the intracellular vacuoles where *Staphylococcus aureus* resides not only effectively eliminates intracellular persisters but also improves the biocompatibility of the drug. This study provides important references for the development of new antibacterial agents against intracellular bacterial pathogens.

Chemical Biology Approach to Reveal the Importance of Precise Subcellular Targeting for Intracellular Staphylococcus aureus Eradication

Bacteria targeting nanoparticles with microenvironment responsive antibiotic release to eliminate intracellular S. aureus and associated infection.

Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureus

Novel antibody-antibiotic conjugate eliminates intracellular S. aureus

Killing of Staphylococcus Aureus Persisters by a Multitarget Natural Product Chrysomycin A.

A Homing Missile‐Like Nanotherapeutic with Single‐Atom Catalytic Sites for In Situ Elimination of Intracellular Bacterial Pathogens

Insights into small-molecule compound CY-158-11 antibacterial activity against Staphylococcus aureus

Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative Bacteria

Structure-Guided Design, Synthesis, and Antivirulence Assessment of Covalent Staphylococcus aureus Sortase A Inhibitors

Bacteria-mimetic nanomedicine for targeted eradication of intracellular MRSA

A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus

Overcoming Planktonic and Intracellular Staphylococcus Aureus-Associated Infection with a Cell-Penetrating Peptide-Conjugated Antimicrobial Peptide

Non-antibiotic strategies for prevention and treatment of internalized Staphylococcus aureus

A bioinspired hierarchical nanoplatform targeting and responding to intracellular pathogens to eradicate parasitic infections

Precise Photothermal Treatment of Methicillin-Resistant S. aureus Infection via Phage Lysin-Cell Binding Domain-Modified Gold Nanosheets

Structure-Based Identification of a Potent Inhibitor Targeting Stp1-Mediated Virulence Regulation in Staphylococcus aureus

Discovery of Sortase A Covalent Inhibitors with Benzofuranene Cyanide Structures As Potential Antibacterial Agents Against Staphylococcus Aureus.

Mechanistic insights and in vivo efficacy of thiosemicarbazones against methicillin-resistant Staphylococcus aureus

Recognition of Staphylococcus Aureus by New Carborane Derivative

Comparative in vitro efficacy of antibiotics against the intracellular reservoir of Staphylococcus aureus

LysSYL: a broad-spectrum phage endolysin targeting Staphylococcus species and eradicating S. aureus biofilms